secwatch.observer — SEC 8-K summary
======================================

Issuer:     Catheter Precision, Inc. (VTAK)
CIK:        0001716621
Form:       8-K
Filed at:   2026-02-12T23:59:59+00:00
Accession:  0001437749-26-003940
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 3.02, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Catheter Precision secures up to $36.5M institutional financing; converts $9M liabilities into equity
--------------------------------------------------------------------------------

- CEO David Jenkins exchanged royalty rights for ~9,490 shares of Series J Preferred Stock convertible into 6,083,005 common shares at $1.56, subject to stockholder approval.
- ATM equity offering program terminated; no future equity lines or forward-priced agreements anticipated.
- Short-term notes converted to long-term debt with maturities of 2-3 years.
- Additional $9M in short and long-term liabilities converted into equity, strengthening balance sheet.
- Up to $36.5M in institutional financing secured to expand market presence and advance growth initiatives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716621/000143774926003940/0001437749-26-003940-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716621/000143774926003940/vtak20260211_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-003940

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer